1
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
13126
Neoplasms
10474
Carcinoma, Non-Small-Cell Lung
6863
Prostatic Neoplasms
6265
Colorectal Neoplasms
5940
Lung Neoplasms
5097
Multiple Myeloma
3573
Pancreatic Neoplasms
3558
Leukemia, Myeloid, Acute
3507
Neoplasm Metastasis
3505
Carcinoma, Hepatocellular
3269
Ovarian Neoplasms
3166
Melanoma
3138
Stomach Neoplasms
3055
Lymphoma
2982
Head and Neck Neoplasms
2599
Recurrence
2553
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2497
Leukemia
2361
Colonic Neoplasms
2327
Brain Neoplasms
2308
Lymphoma, Non-Hodgkin
2268
Rectal Neoplasms
2190
Uterine Cervical Neoplasms
2187
Glioblastoma
2012
Leukemia, Lymphocytic, Chronic, B-Cell
1992
Carcinoma, Renal Cell
1912
Squamous Cell Carcinoma of Head and Neck
1878
Lymphoma, Follicular
1847
Esophageal Neoplasms
1799
Interventions
Mifepristone
1
Etanercept
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Gulf War Illness
×
Clear all
NCT04254627
2025-02-19
E/M
Nova Southeastern University
Phase 1
Active not recruiting
20 enrolled